There is a significant decline in GBS cases and the situation is under control. However, few sporadic cases are still being ...

Barre Syndrome (GBS) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This comprehensive analysis of the Guillain-Barré Syndrome (GBS) pipeline is a testament to ...

Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...

The Food and Drug Administration (FDA) has urged people to ensure that chicken is thoroughly cooked following the detection of Campylobacter jejuni and norovirus in poultry samples amid the ongoing ...

GBS is a rare, neuromuscular emergency that affects at least 150,000 people worldwide each year, with no FDA-approved therapy. The life-altering consequences of GBS were recently detailed in a new ...

Guillain-Barre Syndrome (GBS) is a rare autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, which are responsible for transmitting signals between the ...

Officials confirmed that 60 samples tested negative for Campylobacter jejuni, the bacteria linked to GBS, dispelling concerns over poultry as a possible source of infection The Food and Drug ...

Guillain-Barre Syndrome (GBS) cases in Maharashtra have been on rise since the disease that attacks the peripheral nerves was detected. As of Friday, the tally of suspected and confirmed GBS cases ...